Why the study?
Heart failure diagnosis and therapy have historically relied on echocardiography, prompting an evaluation of whether cardiac magnetic resonance has an increasing role in refining diagnostic accuracy and outcomes for HFpEF.
Does cardiac magnetic resonance imaging improve diagnostic accuracy and outcomes compared to echocardiography in patients with HFpEF?
Does cardiac magnetic resonance imaging improve diagnostic accuracy and outcomes compared to echocardiography in patients with HFpEF?
This review highlights the potential for cardiac magnetic resonance imaging to complement echocardiography in improving the diagnostic precision and management of HFpEF.
May support complementary CMR use with echocardiography in HFpEF; leaves open whether it improves diagnostic accuracy or outcomes.
Clinicians frequently equate symptoms of volume overload to heart failure (HF) but such generalization may preclude diagnostic or etiologic precision essential to optimizing outcomes. HF itself must be specified as the disparate types of cardiac pathology have been traditionally surmised by examination of left ventricular (LV) ejection fraction (EF) as either HF with preserved LVEF (HFpEF-LVEF >50%) or reduced LVEF of (HFrEF-LVEF <40%). More recent data support a third, potentially transitional HF subtype, but therapy, assessment, and prognosis have been historically dictated within the corresponding LV metrics determined by echocardiography. The present effort asks whether this historically dominant role of echocardiography is now shifting slightly, becoming instead a shared if not complimentary test. Will there be a gradual increasing profile for cardiac magnetic resonance as the attempt to further refine our understanding, diagnostic accuracy, and outcomes for HFpEF is attempted?
No takes yet. Share an insight, caveat, or question.
Moreyra et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: